U.S. stocks were lower, with the Dow Jones index falling around 400 points on Monday.
Shares of ImmunityBio, Inc. (NASDAQ:IBRX) rose sharply on Monday after the company reported better-than-expected quarterly financial results.
ImmunityBio reported quarterly losses of 6 cents per share which beat the analyst consensus estimate of losses of 9 cents per share. The company reported quarterly sales of $38.285 million which beat the analyst consensus estimate of $37.020 million.
ImmunityBio shares jumped 22.2% to $10.63 on Monday.
Here are some other big stocks recording gains in today’s session.
- Arcellx, Inc. (NASDAQ:ACLX) shares jumped 77.9% to $114.05 after the company announced it will be acquired by Gilead Sciences.
- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) gained 55% to $8.96 after the company announced FDA approval for BYSANTI tablets.
- Enhabit, Inc. (NYSE:EHAB) gained 22.5% to $13.59 after the company announced it will be acquired by Kinderhook Industries.
- Legend Biotech Corporation (NASDAQ:LEGN) gained 16% to $21.04.
- Getty Images Holdings, Inc. (NYSE:GETY) surged 13.4% to $0.8400 after the company announced it received clearance from the DOJ for the merger with Shutterstock.
- Viking Therapeutics, Inc. (NASDAQ:VKTX) rose 12.3% to $34.86.
- Veris Residential, Inc. (NYSE:VRE) gained 12.1% to $18.80 after the company reported better-than-expected quarterly FFO results and announced it will be acquired by an investor consortium led by Affinius Capital in partnership with Vista Hill Partners.
- Santacruz Silver Mining Ltd. (NASDAQ:SCZM) rose 10.3% to $12.46.
- Tidewater Inc. (NYSE:TDW) gained 9.1% to $79.84 after the company announced it acquired Wilson Sons Ultratug Offshore.
- Moderna, Inc (NASDAQ:MRNA) rose 7.7% to $53.69.
- Vicor Corporation (NASDAQ:VICR) shares gained 6.8% to $181.69.
Photo via Shutterstock
Recent Comments